117 related articles for article (PubMed ID: 32323278)
1. Quantitative Assessment of Fatty Liver using Ultrasound with Normalized Local Variance Technique.
Bae JS; Lee DH; Lee JY; Kim H; Yu SJ; Lee JH; Cho EJ; Lee YB; Han JK; Choi BI
Ultraschall Med; 2021 Dec; 42(6):599-606. PubMed ID: 32323278
[TBL] [Abstract][Full Text] [Related]
2. Quantitative Evaluation of Hepatic Steatosis Using Normalized Local Variance in a Rat Model: Comparison with Histopathology as the Reference Standard.
Bae JS; Lee JY; Lee DH; Kim H; Lee Y; Han JK
Korean J Radiol; 2019 Sep; 20(9):1399-1407. PubMed ID: 31464118
[TBL] [Abstract][Full Text] [Related]
3. Quantitative evaluation of hepatic steatosis using novel ultrasound technology normalized local variance (NLV) and its standard deviation with different ROIs in patients with metabolic-associated fatty liver disease: a pilot study.
Zhao Y; Zhang C; Xu S; Zhang H; Wei S; Huang P; Zhang L; Wong YN; Xu W; Huang P
Abdom Radiol (NY); 2022 Feb; 47(2):693-703. PubMed ID: 34958409
[TBL] [Abstract][Full Text] [Related]
4. Assessment of hepatic steatosis by using attenuation imaging: a quantitative, easy-to-perform ultrasound technique.
Bae JS; Lee DH; Lee JY; Kim H; Yu SJ; Lee JH; Cho EJ; Lee YB; Han JK; Choi BI
Eur Radiol; 2019 Dec; 29(12):6499-6507. PubMed ID: 31175413
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of controlled attenuation parameter measured by transient elastography for the non-invasive assessment of liver steatosis: a prospective study.
Lupșor-Platon M; Feier D; Stefănescu H; Tamas A; Botan E; Sparchez Z; Maniu A; Badea R
J Gastrointestin Liver Dis; 2015 Mar; 24(1):35-42. PubMed ID: 25822432
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
Eddowes PJ; Sasso M; Allison M; Tsochatzis E; Anstee QM; Sheridan D; Guha IN; Cobbold JF; Deeks JJ; Paradis V; Bedossa P; Newsome PN
Gastroenterology; 2019 May; 156(6):1717-1730. PubMed ID: 30689971
[TBL] [Abstract][Full Text] [Related]
7. MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease.
Costa-Silva L; Ferolla SM; Lima AS; Vidigal PVT; Ferrari TCA
Eur J Radiol; 2018 Jan; 98():82-89. PubMed ID: 29279175
[TBL] [Abstract][Full Text] [Related]
8. Quantitative Ultrasound Biomarkers to Assess Nonalcoholic Fatty Liver Disease.
Gao J; Zapata I; Chen J; Erpelding TN; Adamson C; Park D
J Ultrasound Med; 2023 Aug; 42(8):1675-1688. PubMed ID: 36744595
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography.
de Lédinghen V; Vergniol J; Foucher J; Merrouche W; le Bail B
Liver Int; 2012 Jul; 32(6):911-8. PubMed ID: 22672642
[TBL] [Abstract][Full Text] [Related]
10. Two-Dimensional-Shear Wave Elastography with a Propagation Map: Prospective Evaluation of Liver Fibrosis Using Histopathology as the Reference Standard.
Lee DH; Lee ES; Lee JY; Bae JS; Kim H; Lee KB; Yu SJ; Cho EJ; Lee JH; Cho YY; Han JK; Choi BI
Korean J Radiol; 2020 Dec; 21(12):1317-1325. PubMed ID: 32729274
[TBL] [Abstract][Full Text] [Related]
11. How does liver steatosis affect diagnostic performance of 2D-SWE.SSI: assessment from aspects of steatosis degree and pathological types.
Huang Z; Zhou J; Lu X; Zhang T; Xu S; Jin J; Zheng R; Chen S
Eur Radiol; 2021 May; 31(5):3207-3215. PubMed ID: 33119813
[TBL] [Abstract][Full Text] [Related]
12. Quantitative ultrasound, elastography, and machine learning for assessment of steatosis, inflammation, and fibrosis in chronic liver disease.
Destrempes F; Gesnik M; Chayer B; Roy-Cardinal MH; Olivié D; Giard JM; Sebastiani G; Nguyen BN; Cloutier G; Tang A
PLoS One; 2022; 17(1):e0262291. PubMed ID: 35085294
[TBL] [Abstract][Full Text] [Related]
13. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.
Myers RP; Pollett A; Kirsch R; Pomier-Layrargues G; Beaton M; Levstik M; Duarte-Rojo A; Wong D; Crotty P; Elkashab M
Liver Int; 2012 Jul; 32(6):902-10. PubMed ID: 22435761
[TBL] [Abstract][Full Text] [Related]
14. Performance of B-mode ratio and 2D shear wave elastography for the detection and quantification of hepatic steatosis and fibrosis after liver transplantation.
Dubois M; Ronot M; Houssel-Debry P; Brun V; Rayar M; Auger M; Beuzit L; Turlin B; Aubé C; Paisant A
Eur J Gastroenterol Hepatol; 2020 Feb; 32(2):222-230. PubMed ID: 31464783
[TBL] [Abstract][Full Text] [Related]
15. Performance of unidimensional transient elastography in staging non-alcoholic steatohepatitis.
Lupsor M; Badea R; Stefanescu H; Grigorescu M; Serban A; Radu C; Crişan D; Sparchez Z; Iancu S; Maniu A
J Gastrointestin Liver Dis; 2010 Mar; 19(1):53-60. PubMed ID: 20361076
[TBL] [Abstract][Full Text] [Related]
16. Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity.
Pavlides M; Banerjee R; Tunnicliffe EM; Kelly C; Collier J; Wang LM; Fleming KA; Cobbold JF; Robson MD; Neubauer S; Barnes E
Liver Int; 2017 Jul; 37(7):1065-1073. PubMed ID: 27778429
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study.
Ferraioli G; Tinelli C; Dal Bello B; Zicchetti M; Filice G; Filice C;
Hepatology; 2012 Dec; 56(6):2125-33. PubMed ID: 22767302
[TBL] [Abstract][Full Text] [Related]
18. The usefulness of noninvasive liver stiffness assessment using shear-wave elastography for predicting liver fibrosis in children.
Lee S; Choi YH; Cho YJ; Lee SB; Cheon JE; Kim WS; Ko JS; Koh J; Kang GH
BMC Med Imaging; 2021 Apr; 21(1):68. PubMed ID: 33845776
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of T2 relaxation time for hepatic iron grading in rat model of fatty and fibrotic liver.
Jin M; Jiang Y; Zhao Q; Pan Z; Xiao F
PLoS One; 2022; 17(12):e0278574. PubMed ID: 36469532
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of controlled attenuation parameter for liver steatosis in patients with chronic hepatitis B.
Wang CY; Lu W; Hu DS; Wang GD; Cheng XJ
World J Gastroenterol; 2014 Aug; 20(30):10585-90. PubMed ID: 25132779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
